SCN9A (Sodium Channel Nav1.7)
SCN9A
Voltage-gated sodium channel preferentially expressed in nociceptive neurons.
Funktion
Gain-of-function mutations cause inherited pain disorders. Blocking reduces pain signaling.
Arzneimittel, die auf dieses Target wirken
| Arzneimittel | Wirkung | Primär |
|---|---|---|
| Valproic Acid | Blocker | Ja |
| Topiramate | Blocker | Ja |
| Phenytoin | Blocker | Ja |
| Gabapentin | Blocker | Ja |
| Pregabalin | Blocker | Ja |
| Lamotrigine | Blocker | Ja |
| Carbamazepine | Blocker | Ja |
| Furosemide | Inhibitor | Ja |
| Hydrochlorothiazide | Inhibitor | Ja |